World's Best Scientists 2026 revealed!
Masayoshi Takeuchi

Masayoshi Takeuchi

D-Index & Metrics

Medicine

D-Index
82
Citations
20945
World Ranking
16286
National Ranking
510

Masayoshi Takeuchi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Masayoshi Takeuchi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 303 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Masayoshi Takeuchi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Masayoshi Takeuchi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Masayoshi Takeuchi is affiliated with Kanazawa Medical University in Japan and has a substantial research output primarily in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work focuses extensively on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Physiology, and Neurology.

Their principal research topics include Advanced Glycation End Products (AGEs) research, Alcohol Consumption and Health Effects, Diet, Metabolism, and Disease, Liver Disease Diagnosis and Treatment, Alzheimer's disease research and treatments, Diabetic Foot Ulcer Assessment and Management, and Neurological Disorders and Treatments.

Takeuchi has published multiple papers addressing the biochemical and physiological impacts of toxic advanced glycation end products (TAGE). Recent notable publications include:

  • Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle, 2020, Diabetology & Metabolic Syndrome
  • Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage, 2021, Biomolecules
  • Effects of Toxic AGEs (TAGE) on Human Health, 2022, Cells

Frequent coauthors collaborating with Takeuchi include Akiko Sakai, Takanobu Takata, Yoshiki Koriyama, Jun-ichi Takino, and Ayako Furukawa, indicating established research partnerships within the biochemical and medical research communities.

The most common publication venues for Takeuchi's work are:

  • Nutrients (5 publications)
  • Biological and Pharmaceutical Bulletin (5 publications)
  • Diabetology & Metabolic Syndrome (3 publications)
  • Research Square (3 publications)
  • Biomolecules (2 publications)

Masayoshi Takeuchi's research contributions predominantly explore the molecular mechanisms underlying disease processes related to lifestyle and metabolism, with particular attention to the role of toxic advanced glycation end-products. The work extends into various clinical and biomedical domains such as diabetes, liver disease, and neurological conditions, reflecting an interdisciplinary approach within medical and biochemical sciences.

Best Publications

  • Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

    Hideto Yonekura;Yasuhiko Yamamoto;Shigeru Sakurai;Ralica G. Petrova

  • Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

    Yasuhiko Yamamoto;Ichiro Kato;Toshio Doi;Hideto Yonekura

  • Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.

    Sho-ichi Yamagishi;Yosuke Inagaki;Tamami Okamoto;Shinjiro Amano

  • Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

    Tamami Okamoto;Sho ichi Yamagishi;Yosuke Inagaki;Shinjiro Amano

  • Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease

    Nobuyuki Sasaki;Sadamu Toki;Hiroshi Chowei;Toshikazu Saito

  • RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.

    Khin Mar Myint;Yasuhiko Yamamoto;Toshio Doi;Ichiro Kato

  • Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.

    Masayoshi Takeuchi;Sho-ichi Yamagishi

  • Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species- mediated Vascular Endothelial Growth Factor Expression *

    Sho Ichi Yamagishi;Kazuo Nakamura;Takanori Matsui;Yosuke Inagaki

  • AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction

    K.E.I. Fukami;Seiji Ueda;Sho-Ichi Yamagishi;Seiya Kato

  • Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.

    Sho-ichi Yamagishi;Shinjiro Amano;Yosuke Inagaki;Tamami Okamoto

  • Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo

    Masayoshi Takeuchi;Zenji Makita;Zenji Makita;Richard Bucala;Takako Suzuki

  • Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

    Masayoshi Takeuchi;Richard Bucala;Takako Suzuki;Tadatoshi Ohkubo

  • Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.

    Sho-ichi Yamagishi;Yosuke Inagaki;Shinjiro Amano;Tamami Okamoto

  • TAGE (toxic AGEs) theory in diabetic complications.

    Takashi Sato;Mina Iwaki;Noriko Shimogaito;Xuegang Wu

  • Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice

    Keigyou Yoh;Aki Hirayama;Kazusa Ishizaki;Akiko Yamada

  • Glycation--a sweet tempter for neuronal death.

    Seiji Kikuchi;Kazuyoshi Shinpo;Masayoshi Takeuchi;Shoichi Yamagishi

  • Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.

    Hideyuki Hyogo;Sho-ichi Yamagishi;Keiko Iwamoto;Koji Arihiro

  • Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus.

    Yukihiko Kameda;Naoki Asano;Michiyo Yoshikawa;Masayoshi Takeuchi

  • Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

    Yuki Kimura;Hideyuki Hyogo;Sho-ichi Yamagishi;Masayoshi Takeuchi

  • Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells

    Sho-Ichi Yamagishi;Yosuke Inagaki;Yosuke Inagaki;Tamami Okamoto;Tamami Okamoto;Shinjiro Amano;Shinjiro Amano

Frequent Co-Authors

Sho-ichi Yamagishi
Sho-ichi Yamagishi Kurume University
Tsutomu Imaizumi
Tsutomu Imaizumi Kurume University
Naoki Asano
Naoki Asano Hokuriku University
Hiroshi Yamamoto
Hiroshi Yamamoto Komatsu University
Yasuhiko Yamamoto
Yasuhiko Yamamoto Kanazawa University
Richard Bucala
Richard Bucala Yale University
Takao Koike
Takao Koike Hokkaido University
Shigeaki Ohno
Shigeaki Ohno Hokkaido University
Shin Takasawa
Shin Takasawa Nara Medical University
Hiroshi Okamoto
Hiroshi Okamoto Kanazawa University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees is an excellent way to expand your career options in medicine without disrupting your current commitments. Those interested in advanced clinical practice or leadership may consider pursuing a Doctor of Nursing Practice. Some of the cheapest dnp programs are available online, allowing you to save on tuition while earning this prestigious credential.

For registered nurses seeking greater opportunities, online RN to BSN programs provide a convenient and flexible route to advance your education. Discover some of the cheapest rn to bsn online programs to help you progress in your nursing career affordably.

If you have a non-nursing bachelor’s degree and wish to shift into nursing, direct entry msn programs online can help you fast-track your pathway into advanced nursing roles—even if you’re coming from another field.

Looking for programs that are more accessible? Some of the easiest nursing programs to get into offer less competitive admission processes, helping you start your journey in the medical field sooner.

Best Scientists Citing Masayoshi Takeuchi

Trending Scientists

Recently Published Articles